Integer Holdings Corporation
ITGR
Positions held
Your positionsITGR isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- Integer Holdings Corporation operates in the medical devices industry, which is expected to grow significantly due to increasing healthcare demands and technological advancements.
- Revenue increased by 6% compared to the prior quarter, reaching $464 million.
- Operating margin expanded to 9.6%, indicating improved efficiency in operations.
- The company's revenue growth has declined by 2.6% year-over-year, reflecting potential challenges in market demand.
- Earnings growth has decreased by 33.7%, raising concerns about profitability.
- The trailing P/E ratio stands at 34.55, suggesting that the stock may be overvalued compared to its earnings.
Fundamentals
| Market cap | $4.31B | Enterprise value | $5.65B | Trailing P/E | 34.60 | Forward P/E | 18.44 |
| PEG | 2.81 | Price / book | 2.50 | Beta | 0.58 | Dividend yield | 0.00% |
| Revenue growth | -2.6% | Earnings growth | -33.7% | Gross margin | 26.1% | Operating margin | 10.0% |
| Profit margin | 7.0% | ROE | 7.5% | ROA | 3.9% | Debt / equity | 0.79 |
| Current ratio | 3.73 | Free cash flow | $107.67M | Analyst recommendation | none | Mean target | $121.80 |
| 52w high | $126.80 | 52w low | $62.00 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $464M | $440M | $472M | $468M | $476M | — |
| Op margin | 9.6% | 8.1% | 11.6% | 14.1% | 13.2% | — |
| Net income | $23.6M | $16.5M | $48.6M | $39.7M | $37.0M | — |
| Gross margin | 24.3% | 24.9% | 26.4% | 27.0% | 27.1% | — |
| Gross profit | $113M | $110M | $125M | $126M | $129M | — |
| Operating income | $44.6M | $35.5M | $54.5M | $65.9M | $62.9M | — |
- Revenue +6% vs prior quarter ($464M vs $440M).
- Gross margin 24.3% (was 24.9% prior quarter).
- Operating margin expanded to 9.6%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $1.9B | $1.7B | $1.6B | $1.3B | — |
| Op margin | 12.9% | 12.8% | 11.2% | 9.6% | — |
| Net income | $103M | $120M | $90.7M | $66.4M | — |
| Gross margin | 27.0% | 26.7% | 26.3% | 26.0% | — |
| Gross profit | $500M | $459M | $410M | $346M | — |
| Operating income | $239M | $220M | $175M | $128M | — |
Headlines — watch
• [WARN · legal] Integer Gets Early Antitrust Clearance for $5.7 Billion KKR Deal
News
2026-10-07 · Is the Options Market Predicting a Spike in Integer Holdings Stock?
2026-10-07 · 1 Healthcare Stock with Competitive Advantages and 2 We Find Risky
2026-10-06 · 3 Unpopular Stocks with Warning Signs
2026-10-02 · Integer Reports Conversion Period for 2.125% Convertible Notes
2026-10-02 · Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028
2026-09-30 · GMED vs. ITGR: Which Stock Is the Better Value Option?
2026-09-30 · 3 Cash-Producing Stocks with Open Questions
2026-09-30 · Integer Gets Early Antitrust Clearance for $5.7 Billion KKR Deal
2026-09-30 · Integer Receives Early Termination of Hart-Scott-Rodino Waiting Period for Pending Acquisition by KKR
2026-09-29 · Here's Why You Should Retain Integer Holdings Stock in Your Portfolio
2026-09-21 · 3 Low-Volatility Stocks We Think Twice About
Price (daily)
Full chart · RSI · MACD · patterns